#Iota carrageenan nasal spray trial#

Prevention of respiratory infections by povidone-iodine gargle. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. A clinical study on the tolerability of a liposomal povidone-iodine nasal spray: implications for further development. Gluck U, Martin U, Bosse B, Reimer K, Mueller S. Final report on the safety assessment of polyvinylpyrrolidone (PVP). Considerations for the provision of essential oral health services in the context of COVID-19: interim guidance ( 2020). A first step in understanding SARS pathogenesis. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, Van Goor H. SARS-CoV-2 viral load in upper respiratory specimens of infected patients.

The company is in the process of regulatory submissions in several other countries, including India, Brazil and Mexico.Papers of special note have been highlighted as: In June, SaNOtize announced it had received approval from Health Canada to proceed with enrolment of volunteers in Phase III trials, and submitted an application for a New Drug Submission under Health CanadaвЂ™s Interim Order. Releasing a small dose of nitric oxide, a natural nanomolecule with anti-microbial properties including against SARS-CoV-2, Enovid provides a physical and chemical barrier in the nose. The spray received emergency use authorisation in Israel in early July after Phase II trials showed it reduces SARS-CoV-2 viral load, and therefore decrease a personвЂ™s transmission of the virus. Enovid (SaNOtize)Д¬anadian biotech SaNOtizeвЂ™s nitric oxide nasal spray Enovid became available in pharmacies in Israel earlier this month as a treatment for Covid-19. The percentage of participants that developed Covid-19 was significantly lower in the group that received the iota-carrageenan spray compared to placebo вЂ“ 1% and 5.1%, respectively.

#Iota carrageenan nasal spray trial#

Marinomed BiotechвЂ™s red seaweed-derived Carragelose is a broadly active antiviral compound for treating respiratory diseases, approved in the EU, Australia and parts of Asia in the form of nasal sprays, throat sprays and lozenges.Д¬arragelose coats the mucosal tissues of the respiratory tract, forming a physical barrier that helps to protect against viral infection.ДЄccording to a trial conducted by an Argentinian research group, a Carragelose-based nasal spray showed significant efficacy in the prevention of Covid-19 among hospital staff managing patients with the virus. In preclinical studies, IGM-6268 demonstrated significantly greater neutralisation of SARS-CoV-2 with an IgM antibody compared to immunoglobulin G antibodies, the potent neutralisation of all evaluated mutant variants of concern and variants of interest, and the ability to provide effective preventative and therapeutic protection when delivered intranasally in mice.ДЄmerican clinical-stage biotech IGM Biosciences has exclusively licensed the rights to the antibodies used to generate IGM-6268 and related intellectual property from the University of Texas System.

IGM-6268 is an intranasally-administered immunoglobulin M (IgM) antibody treatment candidate for the treatment and prevention of Covid-19. Nasitrol will be marketed by Amcyte in the US through a licensing agreement with Laboratorio Pablo Cassara. There were no differences in the incidence of adverse events between the two groups. The incidence of Covid-19 infection was significantly lower in the Nasitrol group compared with placebo, at 1% versus 5%. What are the potential growth opportunities?.How might the Chinese government react?.Spotlight on Shanghai: what is the situation there?.What is the effect of lockdowns on Chinese ports?.What is the effect of lockdowns on foodservice?.Which multinational companies have been affected?.

Access GlobalDataвЂ™s new whitepaper, China in 2022: the impact of ChinaвЂ™s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022вЂ™s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains.Д¬hinaвЂ™s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. While wanting to protect the country from being overwhelmed by Omicron, ChinaвЂ™s adherence to a Zero-COVID policy is resulting in a significant economic downturn. Introducing the Excellence Awards & Rankings 2022.